State Ledger
Company profile

Akari Therapeutics Plc CIK 1541157

Ticker
AKTX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Tampa, FL 33602
Fiscal year end
2025 (FY)
Market Data
Close
$8.57
Change
+$0.00
Change %
0.00%
Volume
0

AKTX · trading date Oct 8, 2026 · previous close $8.57 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$17.30M
Total assets
$47.89M
Total liabilities
$19.56M
Stockholders' equity
$28.33M
Cash & equivalents
$0
Operating income
-$17.28M
Operating cash flow
-$10.57M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
40.9%
Equity / assets
59.1%
CapEx / revenue
—
Operating cash flow / net income
0.61×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$17.30M $47.89M $19.56M $28.33M
2024 — -$19.79M $50.56M $28.33M $22.23M
2023 — -$10.01M $4.36M $4.58M -$229.0K
2022 — -$17.75M $13.83M $12.04M $1.79M
2015 — -$45.32M $69.89M $21.17M $48.72M
Company Details
SIC code
2834
State of incorporation
X0
Active filer
Yes
Most recent SEC filing
Form 4
2026-08-19
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Tampa, FL 33602
401 EAST JACKSON STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:25 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Florida — Public Companies